ATTI 82° CONGRESSO NAZIONALE SIML
25 September 2019
Vol. 41 No. 4 (2019)

[Bio-hazard in research laboratories]

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
31
Views
15
Downloads

Authors

Objectives. To deal with biohazards in research laboratories (RL), identify exposure features, types and incidence of laboratory-acquired infections/diseases (LAI), and prevention strategies.
Methods. Literature search and appraisal, non-systematic, last 40 years; legislation, guidelines and good practices evaluation. Results. Biohazards are relevant in RL, in various biomedical, agri-food and industrials sectors, with a variety of LAI (especially viruses and bacteria), modes of exposure and transmission; LAI decrease after preventive measures, vaccinations and clinical treatments; LAl underestimation, due to underreporting and subclinical LAI; need to implement and comply with well-known and available technical and scientific guidelines, good medical and laboratory practices; need for specific health education and training; lack of reporting and epidemiologic surveillance systems, with consequent limited data on risk assessment and effectiveness of preventive interventions. Conclusions. The roles of the occupational physician must be underlined, especially for risk assessment, health and clinicepidemiologic surveillance, with the need to monitor effectiveness of preventive interventions, particularly for biosafety and biosecurity levels in RL. It should be useful to increase capacity of epidemiologic surveillance for LAI, through networking or dedicated websites, in order to collect and analyze accidents, injuries, infections, or adverse events occurred to workers in RL.

Altmetrics

Downloads

Download data is not yet available.

Citations

Alessio L, Porru S, e coll. Linee guida per la sorveglianza sanitaria dei lavoratori della sanità esposti a rischio biologico. In: Linee guida per la formazione continua e l'accreditamento del Medico del Lavoro. Società Italiana di Medicina del Lavoro e Igiene Industriale. Apostoli P, Imbriani M, Soleo L, Abbritti G, Ambrosi L Editori, PIME Editrice, Pavia, 2005.
Autori Vari, Coordinatore S. Porru. Rischio biologico nei lavoratori della sanità. G Ital Med Lav 2010; 32(3): 232-322.
Bienek A, Heisz M, Su M. Surveillance of laboratory exposures to human pathogens and toxins: Canada 2016. Can Comm Dis Rep 2017; 43(11): 228-235. DOI: https://doi.org/10.14745/ccdr.v43i11a04
Coelho AC, Garcia Diez J. Biological risks and laboratory-acquired infections: a reality that cannot be ignored in health biotechnology. Front Bioeng Biotechnol 2015; 3: art. 56. Pp. 1-10. DOI: https://doi.org/10.3389/fbioe.2015.00056
Collins DE, Reuter JD, Rush HG, et al. Viral vector biosafety in laboratory animal research. Comp Med 2017; 67(3): 215-221. Dyson MC, Carpenter CB, Colby LA. Institutional oversight of occupational health and safety for research programs involving biohazards. Comp Med 2017; 67(3): 192-202.
Kimman TG, Smit E, Klein MR. Evidence-based biosafety: a review of the principles and effectiveness of microbiological containment measures. Clin Microbiol Rev 2008; 21(3): 403-425. DOI: https://doi.org/10.1128/CMR.00014-08
Howard J, Murashov V, Schulte P. Synthetic biology and occupational risk. J Occup Environ Hyg 2017; 14(3): 224-236. DOI: https://doi.org/10.1080/15459624.2016.1237031
Patterson A, Fennington K, Bayha R, et al. Biocontainment laboratory risk assessment: perspectives and considerations. Pathog Dis 2014; 71: 102-108. DOI: https://doi.org/10.1111/2049-632X.12162
Peng H, Bilal M, Iqbal HMN. Improved biosafety and biosecurity measures and/or strategies to tackle laboratory-acquired infections and related risks. Int J Environ Res Pub Health 2018; 15: 2697. DOI: https://doi.org/10.3390/ijerph15122697
Pike RM. Laboratory-associated infections: incidence, fatalities, causes and prevention. Ann Rev Microbiol 1979; 33: 41-66. DOI: https://doi.org/10.1146/annurev.mi.33.100179.000353
Porru S. Risk assessment, health surveillance and fitness for work in health care workers exposed to infectious agents. Working Group Occupational Infectious Agents, International Commission on Occupational Health (ICOH), 2014.
Schlimgen R, Howard J, Wooley D, et al. Risks associated with lentiviral vector exposures and prevention strategies. J Occup Environ Med 2016; 58(12): 1159-1166. DOI: https://doi.org/10.1097/JOM.0000000000000879
Sewell DL. Laboratory-associated infections and biosafety. Clin Microbiol Rev 1995; 8(3): 389-405. DOI: https://doi.org/10.1128/CMR.8.3.389
Singh K. Laboratory-acquired infections. Clinical Infectious Disease 2009; 49: 142-147. DOI: https://doi.org/10.1086/599104
Traxler RM, Lehman MW, Bosserman EA, et al. A literature review of laboratory-acquired brucellosis. J Clin Microbiol 2013; 51(9): 305530662. DOI: https://doi.org/10.1128/JCM.00135-13
Weiss S. Yitzhaki S, Shapira SC. Lessons to be learned from recent biosafety incidents in the United States. IMAJ 2017; 17: 269-273.

How to Cite



[Bio-hazard in research laboratories]. (2019). Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia, 41(4), 359-364. https://doi.org/10.4081/gimle.523